Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1995 | 09-1995 | 06-1995 | 03-1995 | 12-1994 | |
| Sales | 3,608,000 | 3,413,000 | 3,445,000 | 3,301,000 | 3,247,452 |
| Cost of Goods | 921,000 | 930,000 | 909,000 | 877,000 | 875,000 |
| Gross Profit | 2,687,000 | 2,483,000 | 2,536,000 | 2,424,000 | 2,373,000 |
| Operating Expenses | 1,824,000 | 1,525,000 | 1,674,000 | 1,492,000 | 1,626,000 |
| Operating Income | 863,000 | 958,000 | 862,000 | 932,000 | 746,452 |
| Interest Expense | -275,000 | 0 | 0 | 275,000 | -247,000 |
| Other Income | -1,213,000 | 0 | 0 | 0 | -665,452 |
| Pre-tax Income | -75,000 | 958,000 | 862,000 | 657,000 | 328,000 |
| Income Tax | 67,000 | 269,000 | 254,000 | 0 | 230,000 |
| Net Income Continuous | -142,000 | 689,000 | 608,000 | 657,000 | 98,644 |
| Net Income | $-142,000 | $689,000 | $608,000 | $657,000 | $98,644 |
| EPS Basic Total Ops | -0.07 | 0.34 | 0.30 | 0.32 | 0.05 |
| EPS Basic Continuous Ops | -0.07 | 0.34 | 0.30 | 0.32 | 0.05 |
| EPS Diluted Total Ops | -0.07 | 0.34 | 0.30 | 0.32 | 0.05 |
| EPS Diluted Continuous Ops | -0.07 | 0.34 | 0.30 | 0.32 | 0.05 |
| EBITDA(a) | $863,000 | $958,000 | $862,000 | $932,000 | $746,452 |